We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

178 hedge funds and large institutions have $2.03B invested in Impax Laboratories, Inc. in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 18

46% more call options, than puts

Call options by funds: $8.42M | Put options by funds: $5.76M

44% more capital invested

Capital invested by funds: $1.42B → $2.03B (+$617M)

10% more funds holding

Funds holding: 162 → 178 (+16)

5% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 62

Holders
178
Holders Change
+16
Holders Change %
+9.88%
% of All Funds
4.75%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
37
Increased
59
Reduced
62
Closed
18
Calls
$8.42M
Puts
$5.76M
Net Calls
+$2.66M
Net Calls Change
-$16M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$50.1M
2
Morgan Stanley
Morgan Stanley
New York
+$24.5M
3
KCM
Kornitzer Capital Management
Kansas
+$22.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$21.1M
5
Victory Capital Management
Victory Capital Management
Texas
+$17M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$19.2M
2
TCM
Tekla Capital Management
Massachusetts
-$18.9M
3
TGI
Tradewinds Global Investors
California
-$16M
4
BC
Broadfin Capital
New York
-$15.6M
5
NAP
New Amsterdam Partners
New York
-$14.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
76
Nationwide Fund Advisors
Ohio
$2.58M -$351K -11,998 -13%
KBC Group
77
KBC Group
Belgium
$2.56M +$757K +25,879 +47%
DCM
78
Dupont Capital Management
Delaware
$2.55M +$2.36M +80,590 New
GAM
79
Gotham Asset Management
New York
$2.52M +$1.34M +45,900 +136%
DC
80
Deere & Company
Illinois
$2.47M +$2.28M +78,071 New
NC
81
Northpointe Capital
Michigan
$2.46M +$2.27M +77,705 New
EI
82
EAM Investors
California
$2.44M +$2.26M +77,081 New
Swiss National Bank
83
Swiss National Bank
Switzerland
$2.39M +$64.4K +2,200 +3%
GC
84
Globeflex Capital
California
$2.27M +$782K +26,712 +59%
Ohio Public Employees Retirement System (OPERS)
85
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.21M -$152K -5,194 -7%
ProShare Advisors
86
ProShare Advisors
Maryland
$2.13M -$20.5K -702 -1%
Canada Life
87
Canada Life
Manitoba, Canada
$2.09M +$20.5K +700 +1%
BG
88
BlackRock Group
United Kingdom
$1.95M +$95.9K +3,276 +6%
Renaissance Technologies
89
Renaissance Technologies
New York
$1.95M +$644K +22,000 +56%
TPSF
90
Texas Permanent School Fund
Texas
$1.89M +$819 +28 +0%
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$1.86M +$82.2K +2,808 +5%
Two Sigma Advisers
92
Two Sigma Advisers
New York
$1.85M -$3M -102,400 -64%
MAM
93
Martingale Asset Management
Massachusetts
$1.79M -$405K -13,848 -20%
PAM
94
Paradigm Asset Management
New York
$1.75M +$1.62M +55,200 New
AP
95
AHL Partners
United Kingdom
$1.72M +$1.59M +54,429 New
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$1.72M – – –
MCM
97
Matarin Capital Management
New York
$1.68M – – –
CS
98
Credit Suisse
Switzerland
$1.65M -$931K -31,822 -38%
AIG
99
American International Group
New York
$1.64M -$1.01M -34,359 -40%
State of Tennessee, Department of Treasury
100
State of Tennessee, Department of Treasury
Tennessee
$1.63M -$135K -4,600 -8%
2 3
4
5 6

IPXL Hedge Fund Activity: Q4 2014 in Review

178 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q4 2014, worth a combined $2.03B — up 44% from $1.42B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new IPXL positions and 18 closed out — a net gain of 19 holders — while 59 added to existing stakes and 62 trimmed.

The largest buyer was Franklin Resources, adding an estimated $50.1M. The largest seller was RS Investment Management, exiting entirely with an estimated $19.2M sold.

  • 178 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q4 2014, up from 162 in Q3 2014.
  • Funds reported $2.03B of Impax Laboratories, Inc. stock for Q4 2014, up 44% quarter-over-quarter.
  • 37 funds opened new Impax Laboratories, Inc. positions in Q4 2014 and 18 closed out, a net change of +19 holders.
  • The largest Impax Laboratories, Inc. buyer in Q4 2014 was Franklin Resources, an estimated $50.1M added.
  • The largest Impax Laboratories, Inc. seller in Q4 2014 was RS Investment Management, an estimated $19.2M sold.

Based on aggregated 13F filings for Q4 2014.